biote Corp. Deferred Income Tax Expense (Benefit)
biote Corp. (BTMD) reported Deferred Income Tax Expense (Benefit) of $3.97 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-13
- biote Corp. deferred income tax expense (benefit) for fiscal 2025 was $3.97M.
- biote Corp. deferred income tax expense (benefit) for fiscal 2024 was -$2.90M, a 501.94% decline from fiscal 2023.
- biote Corp. deferred income tax expense (benefit) for fiscal 2023 was $721.00K.
- biote Corp. deferred income tax expense (benefit) for fiscal 2022 was -$743.00K.
| Period end | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $3.97M 10-K · filed 2026-03-13 |
| 2024-12-31 | -$2.90M 10-K · filed 2026-03-13 |
| 2023-12-31 | $721.00K 10-K · filed 2025-03-14 |
| 2022-12-31 | -$743.00K 10-K · filed 2024-03-15 |